Abstract
Infections after lung transplantation are a major cause of morbidity and mortality. Bacteria, fungus and virus are the most common pathogens at the respiratory tract. This short review analyzes pneumonias in LTR with special emphasis on preventive strategies.
Keywords: Lung transplant, infection, pneumonia, prophylaxis
Current Respiratory Medicine Reviews
Title: Pneumonia in Lung Transplant Recipients
Volume: 6 Issue: 3
Author(s): Isabel Otero, Maria P. Sanjuan, Maria del M. Fernandez-Marrube and Hector Verea
Affiliation:
Keywords: Lung transplant, infection, pneumonia, prophylaxis
Abstract: Infections after lung transplantation are a major cause of morbidity and mortality. Bacteria, fungus and virus are the most common pathogens at the respiratory tract. This short review analyzes pneumonias in LTR with special emphasis on preventive strategies.
Export Options
About this article
Cite this article as:
Otero Isabel, P. Sanjuan Maria, del M. Fernandez-Marrube Maria and Verea Hector, Pneumonia in Lung Transplant Recipients, Current Respiratory Medicine Reviews 2010; 6 (3) . https://dx.doi.org/10.2174/157339810791526166
DOI https://dx.doi.org/10.2174/157339810791526166 |
Print ISSN 1573-398X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6387 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Probabilistic Cost-Effectiveness Analysis of Vaccination for Mild or Moderate Alzheimer’s Disease
Current Alzheimer Research Effective Antiviral Medicinal Plants and Biological Compounds Against Central Nervous System Infections: A Mechanistic Review
Current Drug Discovery Technologies Retroperitoneal Cryptococcoma in a Case of Disseminated Cryptococcosis on Antifungal Maintenance Therapy
Current HIV Research Cutting-edge Patents in Alzheimers Disease Drug Discovery: Anticipation of Potential Future Treatments
Recent Patents on CNS Drug Discovery (Discontinued) Recombinant Antibody Fragments for Neurodegenerative Diseases
Current Neuropharmacology Central Nervous System Disorders Associated to Immune Checkpoint Inhibitors
Current Cancer Therapy Reviews Validating Immunotherapy in Alzheimer’s Disease: The EB101 Vaccine
Current Pharmaceutical Design Experimental Research on Nitric Oxide and the Therapy of Alzheimer Disease: A Challenging Bridge
CNS & Neurological Disorders - Drug Targets Uveitis in Rheumatic Diseases
Current Rheumatology Reviews Blood-Brain Barrier Alterations in MDX Mouse, An Animal Model of the Duchenne Muscular Dystrophy
Current Neurovascular Research The Role of Neurogenesis in Neurodegenerative Diseases and its Implications for Therapeutic Development
CNS & Neurological Disorders - Drug Targets Editorial [Hot topic: Inflammation, Immunity, and Alzheimers Disease (Guest Editor: Terrence Town)]
CNS & Neurological Disorders - Drug Targets Clinical Significance of Cytokines and Chemokines in Neuropsychiatric Systemic Lupus Erythematosus
Current Rheumatology Reviews Targeting Mitochondrial Bioenergetics for Alzheimers Prevention and Treatment
Current Pharmaceutical Design On the Future Development of Optimally-Sized Lipid-Insoluble Systemic Therapies for CNS Solid Tumors and Other Neuropathologies
Recent Patents on CNS Drug Discovery (Discontinued) Withdrawal Notice: MMR Vaccine Susceptibility of Viral Agents Causing Meningitis and Meningoencephalitis in Children
Infectious Disorders - Drug Targets Neurotuberculosis: An Overview
Central Nervous System Agents in Medicinal Chemistry Update On Emerging Antivirals For The Management Of Herpes Simplex Virus Infections: A Patenting Perspective
Recent Patents on Anti-Infective Drug Discovery Multi-Target-Directed Ligands and other Therapeutic Strategies in the Search of a Real Solution for Alzheimer’s Disease
Current Neuropharmacology Update on Alzheimer’s Disease Therapeutics
Reviews on Recent Clinical Trials